Omada Health (NASDAQ:OMDA) President Sells $221,827.32 in Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 8,866 shares of Omada Health stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $25.02, for a total transaction of $221,827.32. Following the transaction, the president directly owned 307,372 shares in the company, valued at approximately $7,690,447.44. This represents a 2.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Wei-Li Shao also recently made the following trade(s):

• On Friday, June 12th, Wei-Li Shao sold 4,589 shares of Omada Health stock. The shares were sold at an average price of $17.24, for a total transaction of $79,114.36.

Omada Health Stock Down 1.4%

OMDA opened at $24.04 on Friday. The stock has a market cap of $1.47 billion, a P/E ratio of 480.80 and a beta of 1.73. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The company has a fifty day simple moving average of $20.99 and a 200 day simple moving average of $16.49.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The firm had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. On average, equities research analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently made changes to their positions in OMDA. Hsbc Holdings PLC bought a new stake in shares of Omada Health in the second quarter worth $435,000. Canada Pension Plan Investment Board acquired a new stake in Omada Health in the 2nd quarter valued at $281,000. Legal & General Group Plc acquired a new stake in Omada Health in the 2nd quarter valued at $76,000. The Manufacturers Life Insurance Company bought a new stake in Omada Health during the 2nd quarter worth about $215,000. Finally, Bank of Nova Scotia bought a new stake in Omada Health during the 2nd quarter worth about $617,000.

Analysts Set New Price Targets

A number of research firms recently issued reports on OMDA. JPMorgan Chase & Co. increased their target price on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a research note on Friday. BTIG Research lifted their price target on shares of Omada Health from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday. BMO Capital Markets reiterated an “outperform” rating and issued a $24.00 price target on shares of Omada Health in a report on Friday, August 7th. Needham & Company LLC reissued a “buy” rating and set a $28.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Finally, Evercore restated an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a report on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and an average target price of $26.50.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.